Clinical Trials

“Very commonly these children have a very, very, sick brain and they epilepsy is not just causing them to seize but is also interfering with their ability to learn to walk or to read or to have good sleep,” Dr. Ingram said. … read more at: http://www.kait8.com/2018/11/11/epilepsy-patients-testing-out-new-marijuana-based-medication/

by

“Very commonly these children have a very, very, sick brain and they epilepsy is not just causing them to seize but is also interfering with their ability to learn to walk or to read or to have good sleep,” Dr. Ingram said. … read more at: https://www.wmcactionnews5.com/2018/11/09/epilepsy-patients-testing-out-new-marijuana-based-medication/

by

Researchers at the UM School of Pharmacy are teaming with UMMC to conduct the clinical trial of a marijuana-derived anti-seizure drug. Over four years after Gov. Phil Bryant signed Harper Grace’s Law, allowing clinical trials of a specific marijuana-derived drug, the University of Mississippi Medical Center announced Thursday that those trials had begun. Several agencies, […]

by

DEVON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today reported financial results for the third quarter ended September 30, 2018 and provided an overview of recent operational highlights. “The momentum we established in the first half of 2018 […]

by

A clinical trial of a new drug derived from marijuana to treat seizures in children has received approval, and patients are receiving the medication, according to the physician directing it. Following a rigorous review process, the trial is being conducted by the University of Mississippi Medical Center and the UM School of Pharmacy on UMMC’s […]

by

The administration of cannabidiol reduces anxiety in healthy subjects, according to placebo-controlled clinical trial data published in The Brazilian Journal of Psychiatry. Investigators from the University of Sao Paulo in Brazil and Hebrew University in Israel compared the efficacy of varying doses of CBD versus placebo in a cohort of 57 participants performing a simulated public speaking test. […]

by

Epidiolex, a cannabis-based medicine recently approved by the FDA for the treatment of Dravet and Lennox-Gastaut syndromes, is the first drug containing Cannabidiol or CBD to be officially marketed for epilepsy therapy. Initially approved in June by the Food and Drug Administration (FDA), the US drug agency, the first Cannabidiol-based medicine against two epilepsy form […]

by

Oct. 29 (UPI) — The U.S. Food and Drug Administration announced Monday it is studying whether to add sesame as among foods that must be clearly labeled as an allergen on food packages. Currently, eight allergens must be declared on packaged food labels — peanuts, milk, tree nuts, egg, wheat, soy, shellfish and fish — […]

by

Nov. 1 (UPI) — Canada is experiencing a marijuana shortage two weeks after it legalized recreational use throughout the country. The Canadian government said its official store in Quebec, the country’s second most populous province, would only be open from Thursday to Sunday as there wasn’t enough marijuana to provide stock for the full week, […]

by